Vendor-submitted protocol.
Sponsored by
Bio-Rad Laboratories
Published in
BioTechniques Protocol Guide 2009
Neuroblastoma is a childhood cancer that is derived from precursor cells of the adrenosympathetic system, originating in the adrenal medulla or sympathetic ganglia. To gain insight into the mechanism of action of the MYCN gene in neuroblastoma pathogenesis, we used RNA interference (RNAi) to suppress MYCN expression.